PUBLISHER: The Business Research Company | PRODUCT CODE: 1942457
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942457
A blood glucose monitoring system is a medical device designed to measure and show the concentration of glucose in the blood. It typically includes a compact, portable meter and a test strip where a drop of blood from a fingertip is applied. This system plays a crucial role in diabetes management by enabling individuals to monitor and regulate their blood sugar levels.
There are two main types of blood glucose monitoring systems non-invasive and invasive. Non-invasive systems do not require drawing blood and include devices such as continuous glucose monitoring systems and self-monitoring blood glucose systems for fingertip and alternative site testing. These systems are sold through institutional and retail channels, serving applications in type 2 diabetes, type 1 diabetes, and gestational diabetes.
Tariffs are impacting the blood glucose monitoring systems market by increasing the cost of electronic sensors, semiconductor chips, batteries, plastics, and sterile consumables sourced through global supply chains, leading to higher device manufacturing and distribution costs. The impact is most visible in continuous glucose monitoring systems, self-monitoring blood glucose meters, and disposable test strip segments produced in Asia-Pacific and European manufacturing hubs dependent on imported raw materials and precision components. Retail and institutional buyers are experiencing price pressures and extended procurement cycles as tariff-related costs cascade through distributors and healthcare providers. Nonetheless, tariffs are also encouraging localized component sourcing, regional device assembly, and domestic innovation activities, which may strengthen supply resilience and support long-term market competitiveness.
The blood glucose monitoring systems market research report is one of a series of new reports from The Business Research Company that provides blood glucose monitoring systems market statistics, including blood glucose monitoring systems industry global market size, regional shares, competitors with a blood glucose monitoring systems market share, detailed blood glucose monitoring systems market segments, market trends and opportunities, and any further data you may need to thrive in the blood glucose monitoring systems industry. This blood glucose monitoring systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The blood glucose monitoring systems market size has grown strongly in recent years. It will grow from $17.66 billion in 2025 to $19 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to rise in global diabetes prevalence, increasing awareness of glucose self-monitoring, early commercialization of invasive glucose meters and test strips, expansion of home healthcare and outpatient diabetes care, growing emphasis on glycemic control to reduce complications.
The blood glucose monitoring systems market size is expected to see strong growth in the next few years. It will grow to $24.68 billion in 2030 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising demand for continuous glucose monitoring and flash monitoring systems, increasing adoption of wearable and implantable monitoring devices, higher uptake of remote and connected diabetes management solutions, growing penetration of non-invasive glucose sensing technologies, expanding use of monitoring systems in type 2, type 1, and gestational diabetes care. Major trends in the forecast period include increasing adoption of continuous and real-time blood glucose monitoring solutions, rising shift toward minimally invasive and non-invasive glucose monitoring technologies, growing use of portable, home-based, and self-monitoring glucose devices, expansion of blood glucose monitoring in preventive and chronic disease management, focus on enhancing accuracy, convenience, and patient control in diabetes care.
The growing prevalence of diabetes is expected to drive the expansion of the blood glucose monitoring systems market in the coming years. The increase in diabetes cases can be attributed to factors such as sedentary lifestyles, poor dietary habits, aging populations, and genetic predisposition. Blood glucose monitoring systems are essential for tracking and managing blood sugar levels, supporting disease control, and preventing complications. For example, in December 2023, the Australian Bureau of Statistics, a government agency based in Australia, reported that in 2022, 5.3% of Australians, or around 1.3 million people, were diagnosed with diabetes, with similar rates between males (5.8%) and females (4.9%). The prevalence of diabetes has been steadily rising, particularly with age, reaching 18.7% among individuals aged 75 and older. Type 2 diabetes, which accounts for 87.6% of cases, is the most common form. Factors such as being born overseas, living in disadvantaged areas, and having a disability are linked to higher diabetes rates. As a result, the increasing prevalence of diabetes is expected to drive the growth of the blood glucose monitoring systems market.
Leading companies in the glucose monitoring systems market are focused on advancing technologies such as hybrid closed-loop systems and smartphone applications for real-time data access and management. Hybrid closed-loop systems automate insulin delivery based on real-time glucose readings, enhancing blood sugar control for individuals with diabetes. For instance, in February 2024, DexCom Inc., a US-based manufacturer, introduced Dexcom ONE+ in multiple European countries. This system integrates advanced sensor technology and user-friendly features, including a water-resistant sensor, a transmitter for continuous glucose monitoring, and a smartphone-compatible app. Dexcom ONE+ allows real-time monitoring of blood glucose levels by users and up to ten additional individuals, facilitating shared monitoring.
In September 2023, Abbott Laboratories expanded its diabetes management portfolio by acquiring Bigfoot Biomedical Inc., a US-based company specializing in diabetes management technology. This strategic move strengthens Abbott's capabilities in glucose monitoring and insulin management solutions for diabetic patients.
Major companies operating in the blood glucose monitoring systems market are F. Hoffmann-La Roche Ltd., Medtronic plc, Dexcom Inc., SD Biosensor Co. Ltd., Arkray Inc., Abbott Laboratories, Ypsomed Holding AG, LifeScan IP Holdings LLC, Ascensia Diabetes Care Holdings AG, TaiDoc Technology Corporation, Nemaura Medical Inc., Bionime GmbH, Acon Laboratories Inc., Rossmax International Ltd, AgaMatrix Inc., A. Menarini Diagnostics S.r.l., Medisana GmbH, Intuity Medical Inc., GlucoTrack Ltd., Sinocare Inc., Omron Healthcare Co Ltd, Trividia Health Inc.
North America was the largest region in the blood glucose monitoring systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood glucose monitoring systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the blood glucose monitoring systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The blood glucose monitoring systems market consists of sales of blood glucose meters, test strips, lancets, and lancing devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Blood Glucose Monitoring Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses blood glucose monitoring systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for blood glucose monitoring systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood glucose monitoring systems market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.